Harry Destecroix

Carbometrics Ltd. is a British company that specializes in developing a new glucose sensor chemistry using their proprietary biomimetic glucose binding molecules (GBM). The company is based in Bristol, UK. The company's mission is to help people with diabetes live more normal and longer lives by creating market-leading continuous glucose monitors (CGM). Carbometrics was founded in 2018 by Keith Joseph MacDonald, Anthony Davis, Harry Destecroix, and Andy Chapman. Andy Chapman has been the CEO since 2018.

Science Creates Ventures LLP (Science Creates Ventures) is a venture capital firm founded in 2020 by Harry Destecroix and Jonathan Craton. The firm is headquartered in Bristol, United Kingdom.

Scarlet Therapeutics Ltd. is a company located in the UK that specializes in developing red blood cell-based therapeutics to potentially treat a wide range of diseases. The British company is considered a leader in this field and are currently working on a pioneering platform to generate novel TRBCs.

Acu-Flow Ltd. is a British company founded in 2019 that specializes in developing the next generation of nebulizers for respiratory drug delivery. The company is based in Glasgow, UK. The company's flagship product, Nebu~Flow, is designed to enable the delivery of life-changing treatments.

Imophoron Ltd. is an American company that specializes in cutting-edge vaccine development. The company's scientific advisory board consists of world-leading experts in vaccine technology and infectious diseases. The company is constantly exploring new and innovative ways to combat infection using the latest techniques from science and technology. More information about the company can be found on their website at www.imophoron.com. The company was founded by Fred Garzoni and Richard Edward Bungay has been the CEO of the company since 2022.

Portal Biotech Ltd. is a British biotechnology company founded in 2021 that engages in research and experimental development in the field of biotechnology. The company is based in Abingdon, UK.

Forefront RF Ltd engages in the manufacture of electronic components. The company was founded on January 20, 2020 and is headquartered in Bristol, the United Kingdom.

Cytoseek Ltd. provides cell membrane augmentation technology for enhancement of cell therapies for cancer, heart disease, osteoarthritis, and diabetic wound healing. It enables new functionalities to cell therapies including tissue specific targeting and enhanced cell survivability. The company was founded by Adam Willis Perriman on November 22, 2017 and is headquartered in Bristol, the United Kingdom.

Ziylo Ltd. engages in manufacturing diabetes medicines. The company was founded on May 14, 2014 and is headquartered in Bristol, the United Kingdom.